| 000 | 01367 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250512010142.0 | ||
| 264 | 0 | _c19850617 | |
| 008 | 198506s 0 0 eng d | ||
| 022 | _a0028-1298 | ||
| 024 | 7 |
_a10.1007/BF00692917 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpedding, M | |
| 245 | 0 | 0 |
_aCompetitive interactions between Bay K 8644 and nifedipine in K+ depolarized smooth muscle: a passive role for Ca2+? _h[electronic resource] |
| 260 |
_bNaunyn-Schmiedeberg's archives of pharmacology _cFeb 1985 |
||
| 300 |
_a464-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _a3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aCalcium _xphysiology |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xmetabolism |
| 650 | 0 | 4 |
_aColon _xdrug effects |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Smooth _xdrug effects |
| 650 | 0 | 4 |
_aNifedipine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPotassium _xphysiology |
| 773 | 0 |
_tNaunyn-Schmiedeberg's archives of pharmacology _gvol. 328 _gno. 4 _gp. 464-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00692917 _zAvailable from publisher's website |
| 999 |
_c2587044 _d2587044 |
||